Investor mix
16 investors on record; lead investors include Panakes Partners, TechWald Holding, CDP Venture Capital.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 6 | 38% |
| Angel & family office | 1 | 6% |
| Accelerator & incubator | 6 | 38% |
| Other / undisclosed | 3 | 19% |
Developer of medical devices for the treatment of lymphatic diseases
16 investors on record; lead investors include Panakes Partners, TechWald Holding, CDP Venture Capital.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 6 | 38% |
| Angel & family office | 1 | 6% |
| Accelerator & incubator | 6 | 38% |
| Other / undisclosed | 3 | 19% |